128 related articles for article (PubMed ID: 6785295)
1. Prolactin-secreting pituitary adenomas. V. Increased gonadotroph responsivity in hyperprolactinemic women with pituitary adenomas.
Monroe SE; Levine L; Chang RJ; Keye WR; Yamamoto M; Jaffe RB
J Clin Endocrinol Metab; 1981 Jun; 52(6):1171-8. PubMed ID: 6785295
[No Abstract] [Full Text] [Related]
2. The effect of long-term naloxone infusion on the response of gonadotropins to luteinizing hormone-releasing hormone and on plasma estradiol concentration in a patient with a prolactin-secreting pituitary adenoma.
Lamberts SW; Timmers JM; de Jong FH
Fertil Steril; 1981 Nov; 36(5):678-81. PubMed ID: 6796442
[No Abstract] [Full Text] [Related]
3. Correlation of serum prolactin and LH response to stimulation with LH-RH before and after extirpation of pituitary adenomas with clinical outcome.
Guitelman A; Aparicio NJ; Mancini A; Encinas MT; Levalle O; Schally AV
J Clin Endocrinol Metab; 1977 Oct; 45(4):810-3. PubMed ID: 334790
[No Abstract] [Full Text] [Related]
4. [Prolactin adenoma. Study of gonadotrophic function by the sassoles G LHRH test].
Tourniaire J; Pallo D; Fèvre M; Ponsin G; Mazenod B; Bachelot I; Sassolas G
Nouv Presse Med; 1975 Apr; 4(17):1263-6. PubMed ID: 1098013
[TBL] [Abstract][Full Text] [Related]
5. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
Quigley ME; Judd SJ; Gilliland GB; Yen SS
J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
[TBL] [Abstract][Full Text] [Related]
6. [Hypophyseal gonadotropins after GnRH in patients with pituitary tumors].
Morosini PP; Carletti P; Campanella N; Ferretti GF
Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1243-7. PubMed ID: 6779829
[TBL] [Abstract][Full Text] [Related]
7. Pituitary-ovarian axis responsivity to prolonged gonadotropin-releasing hormone infusion in normal and hyperprolactinemic women.
Caro JF; Woolf PD
J Clin Endocrinol Metab; 1980 Jun; 50(6):999-1004. PubMed ID: 6768765
[No Abstract] [Full Text] [Related]
8. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
Rudolf K; Smid I; Kunkel S; Bazsa-Kassai Z
Zentralbl Gynakol; 1985; 107(14):894-8. PubMed ID: 3929499
[TBL] [Abstract][Full Text] [Related]
9. Gonadal function in fifty men with untreated pituitary adenomas.
Snyder PJ; Bigdeli H; Gardner DF; Mihailovic V; Rudenstein RS; Sterling FH; Utiger RD
J Clin Endocrinol Metab; 1979 Feb; 48(2):309-14. PubMed ID: 218986
[No Abstract] [Full Text] [Related]
10. Pituitary microadenoma and hyperprolactinemia: a cause of unexplained secondary amenorrhea.
Boyar RM; Kapen S; Weitzman ED; Hellman L
N Engl J Med; 1976 Jan; 294(5):263-5. PubMed ID: 811989
[No Abstract] [Full Text] [Related]
11. Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas.
Chanson P; Lahlou N; Warnet A; Roger M; Sassolas G; Lubetzi J; Schaison G; Bouchard P
J Endocrinol Invest; 1994 Feb; 17(2):91-8. PubMed ID: 8006338
[TBL] [Abstract][Full Text] [Related]
12. An FSH and prolactin-secreting pituitary tumor: pituitary dynamics and testicular histology.
Cunningham GR; Huckins C
J Clin Endocrinol Metab; 1977 Feb; 44(2):248-53. PubMed ID: 402377
[TBL] [Abstract][Full Text] [Related]
13. Effects of naloxone on prolactin-secreting pituitary adenomas.
Shima K; Chigasaki H; Seki K
Neurol Med Chir (Tokyo); 1990 Feb; 30(2):109-12. PubMed ID: 1695330
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of prolactin-secreting microadenomas.
Wiebe RH; Kramer RS; Hammond CB
Am J Obstet Gynecol; 1979 May; 134(1):49-55. PubMed ID: 375736
[No Abstract] [Full Text] [Related]
15. [Endocrinological analysis of pituitary adenomas associated with hyperprolactinemia (author's transl)].
Sato O; Hotta H; Nakagawa T; Sohma F; Hasunuma M; Tsuchita H; Tanabe S; Kobayashi K; Inoue Y
No To Shinkei; 1981 Nov; 33(11):1115-23. PubMed ID: 6277351
[No Abstract] [Full Text] [Related]
16. New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist.
McGrath GA; Goncalves RJ; Udupa JK; Grossman RI; Pavlou SN; Molitch ME; Rivier J; Vale WW; Snyder PJ
J Clin Endocrinol Metab; 1993 May; 76(5):1363-8. PubMed ID: 8496331
[TBL] [Abstract][Full Text] [Related]
17. Impaired growth hormone secretion in patients operated for pituitary adenomas.
Hoeck HC; Bang F; Laurberg P
Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
[TBL] [Abstract][Full Text] [Related]
18. [Endocrine diagnosis of pituitary adenomas (author's transl)].
Nakai Y; Oki S; Nakao K; Fukada J; Kinoshita F; Tanaka K; Tsukada T; Imura H
No To Shinkei; 1981 May; 33(5):431-40. PubMed ID: 6266437
[No Abstract] [Full Text] [Related]
19. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
Sassolas G; Lejeune H; Trouillas J; Forest MG; Claustrat B; Lahlou N; Loras B
J Clin Endocrinol Metab; 1988 Jul; 67(1):180-5. PubMed ID: 2967850
[TBL] [Abstract][Full Text] [Related]
20. [Hypophyseal gonadotropins after GnRH in patients with hypophyseal tumors and after hypophysectomy].
Morosini PP; Campanella N; Ferretti GF; Carletti P
Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1248-51. PubMed ID: 6779830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
